GIRK channel activator can provide potential treatments for brain disorders

NewsGuard 100/100 Score

Bottom Line: Potassium channels play an important role in controlling the electrical activity of neurons in the brain.

We identified and characterized a new compound, called GiGA1, that selectively opens a subclass of potassium channels and can functionally suppress seizures in an epilepsy animal model.

Results: GiGA1 was identified in a library of ~750 thousand chemical compounds, using computer-based modeling and virtual screening of an alcohol-binding pocket in the channel. GiGA1 preferentially activates a subset of GIRK channels, those containing the GIRK1 and GIRK2 subunits, most commonly found in the brain.

GiGA1 also activates natively expressed GIRK channels in hippocampal neurons and in turn reduces neuronal excitability. Systemic administration of GiGA1 exhibits anti-seizure properties in an acute epilepsy animal model.

Why the Research Is Interesting: Two reasons. First, the study highlights an integrated approach to identifying ion channel modulators with subunit-specificity. Second, the newly discovered activator of GIRK channels could provide potential treatments for brain disorders, including epilepsy and alcohol use disorder.

Who: Activation of an ion channel in the brain, called GIRK channels, with a selective chemical compound, reduces seizures in mice.

When: A systemic injection of GiGA1 15-30 min prior to inducing convulsions significantly reduced the severity of seizures.

What: The study identified and characterized GiGA1-induced GIRK activity and studied its effect on brain neurons and on suppressing seizures in an epilepsy animal model.

How: Utilizing a structural model of an alcohol bound GIRK channel for virtual screening and subsequent functional analysis, we identified a GIRK channel activator (GiGA1).

Single-cell electrophysiology demonstrated that GiGA1 has similar properties as alcohol, but is more potent, and activates natively expressed GIRK channels in the hippocampus.

Systemic administration of GiGA1 prior to inducing convulsions with pentylenetetrazole (PTZ) significantly reduces the number and severity of seizures.

Study Conclusions: We identified GiGA1 through a virtual screen with ~750 thousand small-molecule compounds and a structural model of the alcohol pocket in GIRK channels. GiGA1 selectively activated GIRK1-containing channels, and, like alcohol, was G protein-independent. GiGA1 activated endogenous GIRK channels in the brain and suppressed drug-induced seizures.

Paper Title: Identification of a G protein-independent activator (GiGA1) of GIRK channels

Said Mount Sinai's Dr. Paul Slesinger of the research: This study 'walks' people through the process of identifying new compounds that selectively modify neuronal activity in the brain.

We focused on a particular type of ion channel, called a GIRK channel, which provides a major source of inhibition in the brain. GIRK channels are implicated in a variety of neurological disorders and are known to be directly affected by alcohol.

We took advantage of our structural understanding of how alcohol modulates GIRK channels, and ultimately identified a subunit-specific compound that activates GIRK channels and mitigates convulsant activity.

This study was a collaborative effort with the groups of Dr. Schlessinger at Mount Sinai and Dr. Marugan at the National Center for Advancing Translational Sciences at NIH.

Source:
Journal reference:

Zhao, Y., et al. (2020) Identification of a G-Protein-Independent Activator of GIRK Channels. Cell Reports. doi.org/10.1016/j.celrep.2020.107770.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Certain progestogens linked to higher brain tumor risk in women, study suggests